Pseudoprogression on Immunotherapy in HNSCC – OncLive
OncLive |
Pseudoprogression on Immunotherapy in HNSCC
OncLive If we think about immunotherapies, we will often give the patient the drug. If the tumor grows and they’re tolerating it, we may say, “Oh, sometimes the tumor gets bigger before it gets smaller,” which has not been reported very much in head and neck … |
|
Enpicom Launches With Plan to Build Software Applications for Immunotherapy Market
GenomeWeb NEW YORK (GenomeWeb) – Dutch bioinformatics software company Enpicom seeks to build a business around ready-to-use software that will initially support target discovery and development in the immunotherapy space, with plans to expand into clinical … |
The Pharma Letter (registration) |
Alligator Bioscience signs new immunotherapy research collaboration
The Pharma Letter (registration) Swedish biotech Alligator Bioscience (STO: ATORX) has entered into a research collaboration agreement has been signed with Professor Ignacio Melero of Spain’s Center for Applied Medical Research (CIMA) and Clínica Universidad de Navarra, Spain, … |
|
CrownBio’s Integrated Oncology Platform Helps Advance Apogenix’s Promising HERA-GITRL Immunotherapy for …
GlobeNewswire (press release) SANTA CLARA, Calif., Sept. 13, 2017 (GLOBE NEWSWIRE) — Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company providing translational … |
|
CrownBio’s Integrated Oncology Platform Helps Advance Apogenix’s Promising HERA-GITRL Immunotherapy for …
GlobeNewswire (press release) SANTA CLARA, Calif., Sept. 13, 2017 (GLOBE NEWSWIRE) — Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company providing translational … |